PharmiWeb Today Story
France, 30 April 2025 – It is official: Opella is now a standalone company. Sanofi announced today the closing of the sale to CD&R of a 50.0% controlling stake of Opella, Sanofi keeping a significant shareholding with a 48.2% stake and Bpifrance owning a 1.8% stake. Opella is stepping into its next chapter with powerful backing, and a clear mission - “Health in Your Hands” - making self-care as simple as it should be.
This is not just a change of ownership. This is a bold move. As the purest and third-largest global player in the €190 billion Over-The-Counter and Vitamins, Minerals and Supplements space, Opella is set to lead in one of the most dynamic, resilient corners of healthcare – where megatrends like aging populations, digital access, and self-care demand are rewriting the rulebook.
Opella is headquartered in France but thinks global. Its 100 brands – including Allegra/Allevia, Dulcolax, Buscopan and Cialis Together – are already trusted names in homes around the world. The self-care environment is still far too complex, leaving most people who suffer without treatment. Opella is grounded in science, with deep consumer obsession and a commitment to sustainability, to offer solutions that help people access the care they deserve.
Julie Van Ongevalle, Opella President and CEO:
“Going independent is not just a milestone. It is our moment. I am proud of our talented team of 11,000 who made this happen. With the right partners and a sharp focus, we are set to reshape how people everywhere manage their health – simply, confidently, and on their terms.”
Nick Linton, H…

Articles

What Does a Pharmaceutical Account Manager Do?
04-Mar-2025

Top 10 Highest Paying Pharma Jobs in 2025
18-Feb-2025

The Impact of AI on Pharmaceutical Sales
13-Feb-2025

What Does a Medical Science Liaison Do?
18-Sep-2023
Featured Events

-
Next Generation Cancer Vaccine Development Summit…
07-Sep-2021 - 09-Sep-2021 -
Reuters Events: Pharma 2021
11-Oct-2021 - 22-Oct-2021 -
PM Society: Measuring Patient Engagement: Opening…
12-Oct-2022 - 12-Oct-2022 -
How to impact, influence & inspire
07-Feb-2023 - 21-Feb-2023 -
Finding the Value in Strategic Outsourcing Partner…
22-Feb-2023 - 22-Feb-2023 -
Genomics and Precision Medicine Expo
23-May-2023 - 24-May-2023
News

-
BRAIN Biotech AG reports preliminary Q2 figures an…
30-Apr-2025 -
BlackfinBio Announces FDA Clearance to Initiate Ph…
30-Apr-2025 -
CellProthera to Present ProtheraCytes® Clinical Da…
30-Apr-2025 -
CSL Vifor and Travere Therapeutics announce standa…
30-Apr-2025 -
Cycuria Therapeutics Launches with the Formation o…
30-Apr-2025 -
Johnson & Johnson’s TAR-200 monotherapy achieves h…
30-Apr-2025